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Objectives The purpose of this study was to determine the mechanisms responsible for reduced aerobic capacity (peak VO2)
in patients with heart failure with preserved ejection fraction (HFPEF).
Background HFPEF is the predominant form of heart failure in older persons. Exercise intolerance is the primary symptom
among patients with HFPEF and a major determinant of reduced quality of life. In contrast to patients with heart
failure and reduced ejection fraction, the mechanism of exercise intolerance in HFPEF is less well understood.
Methods Left ventricular volumes (2-dimensional echocardiography), cardiac output, VO2, and calculated arterial-venous
oxygen content difference (A-VO2 Diff) were measured at rest and during incremental, exhaustive upright cycle
exercise in 48 HFPEF patients (age 69  6 years) and 25 healthy age-matched controls.
Results In HFPEF patients compared with healthy controls, VO2 was reduced at peak exercise (14.3  0.5 ml·kg·min1
vs. 20.4  0.6 ml·kg·min1; p  0.0001) and was associated with a reduced peak cardiac output (6.3  0.2
l·min1 vs. 7.6  0.2 l·min1; p  0.0001) and A-VO2 Diff (17  0.4 ml·dl
1 vs. 19  0.4 ml·dl1, p  0.0007).
The strongest independent predictor of peak VO2 was the change in A-VO2 Diff from rest to peak exercise (A-VO2
Diff reserve) for both HFPEF patients (partial correlate, 0.58; standardized  coefficient, 0.66; p  0.0002) and
healthy controls (partial correlate, 0.61; standardized  coefficient, 0.41; p  0.005).
Conclusions Both reduced cardiac output and A-VO2 Diff contribute significantly to the severe exercise intolerance in elderly
HFPEF patients. The finding that A-VO2 Diff reserve is an independent predictor of peak VO2 suggests that periph-
eral, noncardiac factors are important contributors to exercise intolerance in these patients. (J Am Coll Cardiol
2011;58:265–74) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.02.055Heart failure with preserved ejection fraction (HFPEF)
constitutes 50% or more of elderly patients presenting with
heart failure (HF) (1–3). A cardinal feature of HFPEF is
reduced exercise tolerance, which correlates with symptoms
as well as reduced quality of life (4). Although numerous
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accepted February 15, 2011.studies have investigated the physiological mechanisms for
reduced aerobic capacity (peak VO2) in HF patients with
reduced ejection fraction (EF) (5–7), much less is known
regarding its mechanisms in patients with HFPEF.
See page 275
Kitzman et al. (8) suggested that the reduced peak VO2 in
HFPEF patients was primarily due to reduced cardiac
output (CO) secondary to an inability to increase end-
diastolic (EDV) and stroke volume (SV) via the Frank-
Starling mechanism. In contrast, other investigators found
that the blunted CO was secondary to impaired heart rate
(HR) (9,10) and contractile (9–11) and vasodilator (9–11)
reserve as EDV reserve was preserved.
Several investigators have shown that peripheral factors,
including impaired vascular reserve (10), abnormal blood
flow distribution (7), and skeletal muscle dysfunction (5),
are important contributors to exercise intolerance in patients
with HF and reduced EF. However, no study has focused
on the potentially important role that peripheral noncar-
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Exercise Intolerance in Heart Failure With Preserved EF July 12, 2011:265–74diac factors may play in limiting
exercise performance in HFPEF.
Thus, uncertainty remains re-
garding the mechanisms of the
key symptom of chronic HFPEF,
exercise intolerance, including the
relative roles of reduced CO and
its key components, and arterial-
venous oxygen content difference
(A-VO2 Diff). Therefore, the pur-
pose of the present study was to
measure VO2, left ventricular (LV)
volumes, CO, and calculated
A-VO2 Diff during cycle exercise
in elderly patients with HFPEF
and age-matched healthy controls
(HCs). We tested the hypothesis,
based on our previous observation
in a small number of patients (8)
that the reduced peak VO2 in pa-
ients with HFPEF is due primarily to a blunted EDV
esponse, which limits exercise SV and CO.
ethods
ubjects. As previously described (4,12–14), HFPEF pa-
ients had clinical signs and symptoms of HF as defined by
n National Health and Nutrition Examination Survey HF
linical score of 3 and the criteria of Rich et al. (15,16)
ith normal resting systolic function (LVEF 50%, and no
egmental wall motion abnormalities at rest or during exercise)
nd no evidence of significant anemia or coronary artery,
alvular, infiltrative, pericardial, pulmonary, or renal disease.
atients were recruited by retrospective review of clinic visits
nd hospital discharge records at the Wake Forest University
edical Center, Winston-Salem, North Carolina. Cases of
F were ascertained by retrospective review of clinic visits and
ospital discharge records from the Wake Forest University
edical Center that appeared to potentially fulfill inclusion/
xclusion criteria. Of the resultant 573 participants who were
hen contacted for a screening visit, 59 met the criteria for
FPEF and were enrolled in the study. The subjects in this
eport are a subset of those from a previous study from our
aboratory who had adequate echocardiographic images during
xercise (4). They did not differ significantly from the overall
roup in age, sex, body size, New York Heart Association
NYHA) functional class, or peak VO2.
The HCs (n 28) were recruited from the community and
excluded if they had any chronic medical illness, were taking
any daily prescription medications, had current medical symp-
toms, had abnormal findings on physical examination (includ-
ing blood pressure140/90 mm Hg), had abnormal results on
creening tests (rest and exercise electrocardiogram and spi-
ometry), or were exercising on a regular basis (4,12).
rotocol overview. The study protocol was approved by
Abbreviations
and Acronyms
A-VO2 Diff  arterial-venous
oxygen difference
CO  cardiac output
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
HC  healthy control
HF  heart failure
HFPEF  heart failure with
preserved ejection fraction
NYHA  New York Heart
Association
peak VO2  peak exercise
oxygen consumption
(aerobic capacity)
SV  stroke volumehe Wake Forest University Institutional Review Board, andritten consent was obtained from all participants. Partic-
pants reported to the laboratory in the morning and were
valuated in the post-absorptive state having all cardioactive
edications, caffeine, and nicotine withheld since the eve-
ing before as previously described (4). Both testing and
nalysis were performed by individuals blinded to partici-
ant groups and clinical information.
ardiopulmonary exercise testing. Exercise testing was
erformed on an upright cycle ergometer. The initial power
utput was set at 12.5 W, increased to 25 W for 3 min, and
ollowed thereafter by 25-W increments every 3 min
13,14,17). Expired gas analysis was performed using a
ommercially available metabolic measurement system
Medgraphics CPX, Medical Graphics Corp., St. Paul,
innesota), with the highest values obtained during the
nal 30 s used as the peak score. Ventilation threshold and
O2 work rate relationship was calculated using standard
ethods (18,19).
est and exercise echocardiography. Echocardiograms
ere obtained using a Sonos 5500 ultrasound imaging
ystem (Hewlett-Packard, Palo Alto, California) with a
ultiple-frequency transducer, as previously described
4,20). Adequate acoustic windows were available in 48 of
9 HFPEF participants and 25 of 28 HCs. Standard
-dimensional images were obtained in the parasternal long
nd short axes, and apical 4- and 2-chamber views. Pulsed-
ave Doppler tracings of mitral valve inflow velocity were
ecorded at the leaflet tips (21,22). During exercise, the
onographer focused solely on capturing optimal apical
-chamber views for LV volume assessment.
An experienced echosonographer trained in quantitative
nalyses who was unaware of participant group or condition
nalyzed all images by tracing the endocardial borders
uring diastolic and systolic frames from 3 digital cine loops,
nd the results were averaged as previously described (4,20).
he EDV and end-systolic volume (ESV) were calculated
sing the single-plane ellipsoid apical 4-chamber area-
ength method (23). The SV, CO, and EF were derived
rom standard equations, whereas A-VO2 Diff was calcu-
lated as: VO2  CO.
We validated 2-dimensional resting echocardiographic
olume measurements of EDV against EDV derived from
adionuclide angiography (Fick equation derived SV/
adionuclide angiography EF) in 14 healthy subjects be-
ween 22 and 73 years of age. Image analysis was blinded to
he identity of the subject. Mean EDV by echocardiography
as 105.9  5.9 ml and 114.9  7.6 ml by the Fick/
radionuclide angiography. Individual patient data were
highly correlated (r  0.82). In addition, echocardiography
showed an excellent day-to-day reproducibility (r  0.88)
and intraobserver and interobserver variability (r 0.96 and
0.94, respectively) (24,25).
Statistical analysis. Comparison between groups for con-
tinuous variables was assessed using the Student t test and a
chi-square test for categorical variables. Outcome variables
were adjusted for sex, whereas LV volumes were addition-
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July 12, 2011:265–74 Exercise Intolerance in Heart Failure With Preserved EFally adjusted for body surface area. General linear models
were used to compare variables adjusted for covariates. The
relationship between LV volumes/hemodynamics and in-
creasing workload was assessed by repeated-measures anal-
ysis of covariance using general linear and polynomial mixed
models (26). Given that some individuals with HFPEF
(n  14) could not exercise beyond 25 W, repeated
measures between groups were limited to rest and 12.5-W,
25-W, and peak exercise workloads. No value was used
twice. Multivariable linear regression models were used to
estimate the relative contributions of independent variables
to exercise capacity (peak VO2) (27). Variables were selected
priori based on previous studies and literature relevant to
he study population (8–10,12,22). A 2-sided p value0.05
as determined as significant. All statistical analyses were
erformed with SAS version 9.1 (SAS Institute, Cary,
orth Carolina) using PROC MIXED for analysis of
epeated measures.
esults
aseline demographics, ventricularmorphology, and function.
FPEF subjects were predominantly older, white women
ith a history of hypertension and NYHA functional class
Participant CharacteristicsTable 1 Participant Characteristics
Characteristic
HFPEF Patients
(n  48)
HCs
(n  25) p Value
Age, yrs 69 6 68 5 0.68
Female 41 (85) 13 (52) 0.01
White 39 (81) 25 (100) 0.01
Weight, kg 81 16 72 12 0.02
Body mass index, kg/m2 30.6 6.0 25.0 3.6 0.0001
Body surface area, m2 1.85 0.2 1.81 0.2 0.46
Systolic blood pressure, mm Hg 146 19 130 10 0.0001
Diastolic blood pressure, mm Hg 82 8 80 7 0.19
Mean blood pressure, mm Hg 103 10 97 6 0.001
Pulse pressure, mm Hg 63 17 50 12 0.001
Brain natriuretic peptide 55 98 10 11 0.02
Doppler diastolic function
Normal 7 (15) 19 (76) 0.0001
Abnormal relaxation 33 (70) 6 (24) 0.0002
Pseudonormal 7 (15) 0 0.09
Diabetes mellitus 8 (17) — —
History of hypertension 39 (81) — —
NYHA functional class
II 31 (65) — —
III 17 (35) — —
Medications
ACE inhibitors 14 (29) — —
Digoxin 10 (21) — —
Diuretics 28 (58) — —
Beta-blockers 11 (23) — —
Calcium-channel blockers 18 (38) — —
Nitrates 4 (8) — —
Values are mean  SD or n (%).
ACE  angiotensin-converting enzyme; HC  healthy control; HFPEF  heart failure with
preserved ejection fraction; NYHA  New York Heart Association.I symptoms (Table 1). Body mass, systolic, mean, and pulseressures were significantly higher in HFPEF patients than
n HCs (Table 1).
The LV wall thickness, LV mass/EDV ratio, EF, and
trial filling velocity were significantly higher, whereas the
/A ratio was lower in HFPEF patients than in HCs,
ndicative of abnormal LV diastolic filling (Table 2). No
ifference was found between groups for deceleration time
r isovolumic relaxation time.
O, A-VO2 Diff, and peak VO2. Exercise time, peak
power output, HR, CO, A-VO2 Diff, and peak VO2 were
ignificantly reduced in HFPEF patients compared with
Cs (Table 3, Fig. 1). The results for these major outcomes
emained unchanged when adjusting for peak power output
nd respiratory exchange ratio. VO2 at the ventilation
threshold and the VO2-work rate relationship were signifi-
antly reduced in HFPEF patients compared with HCs
Table 3).
Mean arterial pressure was increased during submaximal
xercise at 25 W in HFPEF patients compared with HCs
116  2.0 mm Hg vs. 107  2.1 mm Hg; p  0.002) and
as not significantly different at peak exercise (122  2.1
mm Hg vs. 118 2.5 mm Hg; p 0.17), showing a pattern
similar to that of systolic blood pressure (Fig. 1F).
LV and EF during submaximal and peak exercise. Peak
exercise SV and EF were not different between groups
(Figs. 2A and 2B); however, at 25 W, HFPEF patients had
a lower SV than did HCs (Fig. 2A). The significantly lower
baseline EDV in HFPEF patients versus HCs persisted to
a similar degree during exercise (Fig. 2C). Baseline ESV
was significantly higher in HCs and successively decreased
during exercise such that no difference was found between
groups at peak exercise (Fig. 2D).
The absolute change and percentage of change in EDV
were not significantly different between groups during
low-level exercise where most of the change in EDV
occurred (Figs. 3A1 and 3A2). The percentage of change in
EDV from rest to peak exercise was greater in HFPEF
patients than HCs (10.3  2.0% vs. 2.9  2.1%, p  0.03)
Supine Resting Echocardiographicand Doppler MeasuresTable 2 Supine Resting Echo ardiographicand Doppler Measures
Characteristic
HFPEF Patients
(n  48)
HCs
(n  25) p Value
Ejection fraction, % 59 1.1 53 1.3 0.0001
Septal wall thickness, cm 1.23 0.05 0.84 0.05 0.0001
Posterior wall thickness, cm 1.11 0.03 0.92 0.04 0.0001
LV mass, g 161 7 142 8 0.06
LV mass, g/m2.7 41 2 34 2 0.03
LV mass/EDV ratio 2.2 0.1 1.5 0.1 0.02
E-wave velocity, cm/s 55 3 54 3 0.88
A-wave velocity, cm/s 81 5 58 5 0.001
E/A ratio 0.76 0.04 0.93 0.04 0.002
Deceleration time, ms 260 10 254 9 0.65
Isovolumic relaxation time, ms 122 4 117 4 0.42
Values are mean  SE. All comparisons adjusted for sex.
A  atrial mitral inflow Doppler; E  early mitral inflow Doppler; EDV  end-diastolic volume;
LV  left ventricular; other abbreviations as in Table 1.
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Exercise Intolerance in Heart Failure With Preserved EF July 12, 2011:265–74(Fig. 3A2). The absolute or percentage of change in ESV
was not different between groups during submaximal exer-
cise, but the reduction in ESV at peak exercise was blunted
in HFPEF patients (Figs. 3B1 and 3B2). The absolute or
percentage of change in SV was not different between
groups during submaximal or peak exercise (Figs. 3C1 and
C2). The change in HR was significantly reduced in
FPEF patients at peak exercise (Figs. 3D1 and 3D2). A
imilar pattern was seen for CO, in which CO response was
ot different between groups at low-level exercise but was
ecreased in HFPEF patients at peak exercise (Figs. 3E1
nd 3E2). The absolute changes in EF and systolic blood
ressure were not different between groups (p  0.11 and
 0.19, respectively); however, the percentage of change
or both measures was lower in HFPEF patients compared
ith HCs (p  0.04 and p  0.02, respectively). The
bsolute change and percentage of change in A-VO2 Diff
ere lower in HFPEF patients compared with HCs (p 
.008 and p  0.002, respectively). Finally, overall results
emained unchanged when additional analyses were per-
ormed when 25-W values from subjects whose peak power
utput was 25 W were included for submaximal analyses.
eterminants of peak VO2. The change in A-VO2 Diff
from rest to peak exercise was the strongest independent
predictor of peak VO2 for both HC (partial correlate, 0.61;
tandardized  coefficient, 0.41; p  0.005) and HFPEF
patients (partial correlate, 0.58; standardized  coefficient,
.66; p  0.0002) (Table 4). Among HCs, the change in
V (partial correlate, 0.47; standardized  coefficient, 0.39;
 0.04) was more highly correlated with peak VO2 than
he change in HR (partial correlate, 0.41; standardized 
coefficient, 0.27; p  0.07). In HFPEF patients, the reverse
as observed in that the change in HR (partial correlate,
.53; standardized  coefficient, 0.43; p 0.0007) was more
highly correlated with peak VO2 than the change in SV
partial correlate, 0.35; standardized  coefficient, 0.32; p 
.04).
The cardiac contribution to peak VO2 was also analyzed
as CO rather than its factors (HR and SV). Among the
Cardiopulmonary Exercise PerformanceTable 3 Cardiopulmonary Exercise Performa
Parameter
Exercise time, min
Peak power output, W
Peak oxygen consumption, ml·min1
Peak oxygen consumption, ml·kg·min1
Respiratory exchange ratio
Oxygen consumption at ventilation threshold, ml·min1
Oxygen consumption at ventilation threshold, ml·kg·min1
Ventilation threshold, % peak oxygen consumption
Ventilation/carbon dioxide slope
Oxygen uptake–work rate relationship
Values are mean  SE. All comparisons adjusted for sex except for re
Abbreviations as in Table 1.HFPEF patients, in univariate analysis, the correlation withpeak VO2 of rest to peak exercise change in CO (0.31; p 
.04) was significant but somewhat weaker than that for the
est to peak exercise change in A-VO2 Diff (0.45; p 
.004). In multivariate analysis, the partial correlate with
eak VO2 of the rest to peak exercise change in CO (0.71;
 0.0001) was relatively similar to the rest to peak exercise
change in A-VO2 Diff (0.72; p  0.0001).
These overall results were not significantly changed after
djustment for beta-blocker or calcium-channel blocker
herapy. Overall results were also unchanged if LV volume
ata were analyzed by indexing to body surface area.
iscussion
n this study, we sought to understand the mechanisms of
he severe exercise intolerance observed in elderly patients
ith HFPEF by measuring LV volumes/hemodynamics
nd expired gases in a group of well-characterized patients
ith HFPEF compared with HCs. The major new finding
f this study was that the reduced peak VO2 in HFPEF
patients compared with HCs was the result of both reduced
peak CO and A-VO2 Diff. In turn, the reduced peak CO
as due primarily to reduced peak and reserve HR; how-
ver, contrary to our hypothesis, the reduced peak VO2 was
ot attributable to failure of the left ventricle to dilate as the
bsolute change in EDV from rest to peak exercise was not
ignificantly different between HFPEF patients and HCs.
inally, our finding that the change in A-VO2 Diff from rest
o peak exercise was a strong, independent predictor of peak
O2 in HFPEF patients suggests that, as has been found in
atients with HF and reduced EF (5,7,28), noncardiac
eripheral factors play an important role in limiting their
xercise capacity.
O, A-VO2 Diff, and VO2. Few studies have examined
eak VO2 in HFPEF patients (4,8,9,29), and even fewer
have made the measurements required to calculate A-VO2
Diff (4,8). We did this by simultaneously measuring VO2
and CO, a method that has been used in studies evaluating
mechanisms of exercise intolerance in HF patients with
HFPEF Patients
(n  48)
HCs
(n25) p Value
8.2 0.4 10.6 0.4 0.0001
58 3.1 83 3.6 0.0001
1,206 38 1,463 45 0.0001
14.3 0.5 20.4 0.6 0.0001
1.10 0.01 1.17 0.02 0.008
793 27 838 30 0.30
9.4 0.3 11.5 0.4 0.001
67 2 58 2 0.001
34.7 1.0 32.2 1.1 0.08
7.0 0.3 9.7 0.6 0.0001
ry exchange ratio and the oxygen uptake–work relationship.ncereduced EF (6,30). Although submaximal CO, A-VO2 Diff,
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July 12, 2011:265–74 Exercise Intolerance in Heart Failure With Preserved EFand VO2 were similar between groups, different physiolog-
cal mechanisms were used by HFPEF patients and HCs to
ncrease CO (Fig. 1). The smaller SV in HFPEF patients
as associated with a higher HR, whereas the opposite
esponses were found for HCs. Furthermore, the blunted
ubmaximal SV reserve is likely due to decreased contrac-
ility as the changes in EDV and systemic vascular resistance
Figure 1 Comparison at Seated Rest, 12 W, 25 W, and Peak E
(A) Oxygen consumption, (B) arteriovenous oxygen content difference, (C) heart r
pressure. All variables adjusted for sex (*p  0.05). The p value at the upper left
sent healthy controls (HC) and blue solid lines represent patients with heart failurSVR) were similar between groups. Despite these differ- tnces, our finding of a plateau in SV during submaximal
xercise is consistent with findings of previous studies in
ealthy older sedentary individuals (31,32) and HF patients
ith reduced EF (5,6).
O, A-VO2 Diff, and peak VO2. Unlike submaximal
exercise, and partly in contrast to our hypothesis, the
marked reduction in peak VO2 in HFPEF patients was due
se Between HFPEF Patients and HCs
) cardiac output, (E) systemic vascular resistance (SVR), and (F) systolic blood
h panel represents the group-by-intensity interaction. Red dashed lines repre-
preserved ejection fraction (HFPEF).xerci
ate, (D
of eac
e witho both decreased peak CO and A-VO2 Diff. In turn, the
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Exercise Intolerance in Heart Failure With Preserved EF July 12, 2011:265–74lower peak CO was secondary to the blunted peak (and
reserve) HR as the SV was similar for HFPEF patients and
HCs. These results are consistent with those of Brubaker et
al. (12) and others (9,10,33–35) who demonstrated that
chronotropic incompetence contributes to exercise intoler-
ance in HFPEF patients.
Despite peak SV being similar between the groups, the
mechanisms that underlie the SV response differed between
groups. Specifically, HFPEF patients relied to a greater
extent on LV filling (EDV reserve), whereas HCs relied on
increased LV emptying (ESV reserve) to increase the SV
from rest to peak exercise (36). These divergent responses
did not appear to be related to differences in afterload
because exercise SVR was not different between groups;
however, it may be the result of reduced contractile reserve
as peak power index, single-beat end-systolic elastance, and
preload-recruitable stroke work are reduced during sub-
maximal and peak exercise in HFPEF patients (10).
To date, 5 studies have examined the physiological
mechanisms of exercise intolerance in HFPEF patients
(Table 5) (8–11,37). Kitzman et al. (8) compared LV
volume/hemodynamic responses to upright cycle exercise in
Figure 2 Comparison at Seated Rest, 12 W, 25 W, and Peak E
(A) Stroke volume, (B) ejection fraction, (C) end-diastolic volume, and (D) end-sys
Ejection fraction adjusted for sex (*p  0.05). The p value at the upper left of ea
and blue solid lines represent patients with HFPEF. Abbreviations as in Figure 1.7 HFPEF patients (1 amyloid, 2 hypertrophic cardiomyop- pathy, and 4 with hypertension) and 10 age-matched con-
trols. The novel finding was that the lower peak VO2 in
FPEF patients versus HCs was due to reduced peak CO
nd A-VO2 Diff, findings consistent with our results (Fig. 1).
Contrary to our present data in a larger, more uniform and
better characterized cohort of HFPEF patients, the blunted
peak SV was attributed to an inability to use the Frank-
Starling mechanism because a 2.5-fold increase in LV filling
pressure from rest to peak exercise was not associated with
a concomitant increase in EDV. The divergent EDV
response between studies may be due to the type of HF
patients studied. Specifically, Kitzman et al. (8) included
HF patients (i.e., hypertrophic cardiomyopathy and amy-
loid) who have limited use of the Frank-Starling mechanism
during exercise (38), whereas in the present study, these
patients were excluded. Importantly, however, in our previ-
ous study, peak exercise A-VO2 Diff, which at that time was
easured invasively by direct oximetry, was reduced com-
ared with controls, supporting the findings of our present
tudy.
Mader et al. (37) used right heart catheterization and
xpired gas analysis during supine exercise in 14 HFPEF
se Between HFPEF Patients and HCs
olume. Left ventricular volumes adjusted for sex and body surface area.
el represents the group-by-intensity interaction. Red dashed lines represent HCxerci
tolic v
ch panatients (mean age 69 years) and 8 age- and sex-matched
271JACC Vol. 58, No. 3, 2011 Haykowsky et al.
July 12, 2011:265–74 Exercise Intolerance in Heart Failure With Preserved EFFigure 3 Comparison of Change and Percentage of Change From Rest to 12 W, Rest to 25 W, and
Rest to Peak Exercise in HFPEF Patients and HCs
End-diastolic volume (A1 and A2), end-systolic volume (B1 and B2), stroke volume (C1 and C2), and cardiac output (E1 and E2) adjusted for sex and body surface
area. Heart rate (D1 and D2) adjusted for sex (*p  0.05, †p  0.01). Solid bars  HFPEF patients; open bars  HCs. Abbreviations as in Figure 1.
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Exercise Intolerance in Heart Failure With Preserved EF July 12, 2011:265–74controls. The reduced peak VO2, in HFPEF patients versus
ontrols was primarily due to a lower peak cardiac and to a
esser extent to reduced peak A-VO2 Diff. In turn, the lower
peak CO was secondary to a lower peak SV because the
peak HR was similar between groups. Our finding of lower
SV, CO, and A-VO2 Diff during upright peak cycle exercise
onfirms and extends the findings obtained during supine
xercise.
Borlaug et al. (9) compared the cardiovascular responses
uring upright cycle exercise in 17 HFPEF patients (pre-
ominantly older, obese, diabetic, and hypertensive black
omen with LV hypertrophy) and 19 age-, sex-, and
omorbidity-matched control subjects without HF. The
ain finding was that the reduced peak VO2 in HFPEF
atients compared with controls was due to impaired
hronotropic, vasodilator, and CO reserve. In a follow-up
tudy, Borlaug et al. (10) confirmed that the reduced
xercise capacity in HFPEF patients (mean age 67 years)
ersus age-matched hypertensive controls (n  19) without
F and healthy controls (n  10) was secondary to reduced
chronotropic, inotropic, and vasodilator reserve.
Predictors of Peak Oxygen ConsumptionTable 4 Predictors of Peak Oxygen Consumption
Variable
Univariate Predictor
Simple Correlation p Value Partial Correlate Un
HCs
Age 0.18 0.35 0.20
Sex 0.80 0.0001 0.69
SBP 0.08 0.70 0.15
HR 0.23 0.24 0.41
SV 0.37 0.06 0.47
A-VO2 Diff 0.10 0.65 0.61
HFPEF patients
Age 0.48 0.0001 0.29
Sex 0.52 0.0001 0.60
SBP 0.07 0.607 0.03
HR 0.39 0.003 0.53
SV 0.14 0.354 0.35
A-VO Diff 0.45 0.004 0.58
  change from rest to peak exercise; A-Vo2 Diff  arterial-venous oxygen content difference; H
Studies of Determinants of Exercise Intolerance in HFPEFTable 5 Studies of Determinants of Exercise Intolerance in HFP
Kitzman et al. (8)
HFPEF vs. AMC
Borlaug et al. (9)
HFPEF vs. ASCC
Ennezat et al. (11)
HFPEF vs. HYPER
Peak VO2 2 2 NR
CO 2 2 2
A-VO2 Diff 2 NR NR
HR 2 2 ↔
EDV 2 ↔ ↔
ESV ↔ NR 2
SV 2 ↔ 2
EF 2 2 2
SVR NR 2 2
  peak exercise minus rest change; AMC  age-matched controls; ASCC  age-, sex-, and c
HYPER hypertensive age-matched controls; NR not reported; SVR systemic vascular resistance; VO2
group;↔  no difference between HFPEF and comparison group; other abbreviations as in Tables 1, 2,Last, Ennezat et al. (11) assessed ventricular-vascular
function during semirecumbent cycle exercise in 25 white
HFPEF patients (predominantly older women with hyper-
tension) and 25 age-, sex-, and comorbidity-matched con-
trols. These investigators reported that the blunted CO
reserve was the result of decreased contractile and vasodila-
tor reserve as chronotropic and EDV reserve were similar
between groups.
Although the differences between the findings of these
studies may not be explainable by any single factor, there were
multiple differences in patient populations (racial composition,
sex, and comorbidities) of both the patients and controls as well
as in methods and study design that make them difficult to
directly compare. For instance, nearly all of the controls
included in the Borlaug et al. (9) and Ennezat et al. (11) studies
were female and hypertensive. In contrast, 52% of our controls
were female and all were healthy and free of chronic medical
conditions, particularly hypertension.
Determinants of peak VO2. In the study by Borlaug et al.
9), HR, CO, and SVR were significantly related to peak
O2 in HFPEF patients and controls who had similar
Multivariable Predictor
rdized Coefficient (B) Standardized Coefficient t Statistic p Value
9.28 0.10 0.89 0.39
437.83 0.56 3.99 0.001
1.98 0.07 0.66 0.51
5.35 0.27 1.90 0.07
13.79 0.39 2.27 0.04
3,226.31 0.41 3.25 0.005
7.67 0.19 1.77 0.08
310.30 0.48 4.49 0.0001
0.21 0.02 0.17 0.87
5.05 0.43 3.72 0.0007
11.25 0.32 2.18 0.04
3,627.31 0.66 4.25 0.0002
art rate; SBP  systolic blood pressure; SV  stroke volume; other abbreviations as in Table 1.
Borlaug et al. (10)
Maeder et al. (37)
HFPEF vs. AMC
Current Study
HFPEF vs. AMCEF vs. AMC HFPEF vs. HYPER
2 2 2 2
2 2 2 2
NR NR ↔ 2
2 2 ↔ supine,2 upright 2
↔ ↔ NR ↔
2 2 NR 2
NR NR 2 ↔
2 2 NR 2
2 2 2 ↔
ity-matched controls; CO  cardiac output; EF  ejection fraction; ESV  end-systolic volume;standaEF
HFP
omorbid
 oxygen uptake;2 lower in HFPEF vs. comparison group;1 higher in HFPEF vs. comparison
and 4.
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present study, we found that in addition to CO, the change
in A-VO2 Diff from rest to peak exercise was a strong,
independent predictor of peak VO2 in HFPEF patients and
HCs. This suggested that peripheral noncardiac factors
may contribute to limiting exercise performance in el-
derly HFPEF patients as well as in healthy older sedentary
individuals. This finding is not surprising given that capac-
ity for both oxygen delivery and use plays an important role
in limiting exercise performance in healthy older individuals
as well as diseased populations (4–7,28,39).
Study limitations. Although we screened participants with
HFPEF to reduce the confounding effects of medical
comorbidities, this strategy had the potential to introduce
selection bias; however, the demographics and the anthro-
pometric measurements of the HFPEF group closely
matched those of population-based studies (1–3).
Our peak SV and CO may be underestimated due to the
technical challenge of acquiring echocardiographic images
during peak exercise. Only patients with adequate acoustic
windows were able to be included. However, this technique
has been used successfully in previous publications by
investigators in our group and others (40–42).
A-VO2 Diff was not independently measured, but was
alculated using the Fick equation as VO2/CO. The calcu-
lated peak A-VO2 Diff in our HF and HFPEF subjects is
somewhat higher than that previously reported by others
(6,8,31). However, the pattern of our results is relatively
similar to those reported previously in which A-VO2 Diff
as measured directly using invasively obtained systemic
nd pulmonary arterial blood samples (6,8,39). Moreover,
he key finding that A-VO2 Diff is reduced and contributes
to reduced peak O2 in HFPEF patients is not surprising,
iven that A-VO2 Diff is known to be an important
ontributor to peak VO2 in healthy persons and in HF
patients with reduced EF (4–7,28). Finally, because each
group was measured using similar methods, comparisons
between groups are meaningful.
We and others have previously reported that peak HR is
blunted in HFPEF patients (9,10); however, it is not
possible to exclude the possibility that the effects of beta-
blocker medications in some of the HFPEF patients may
have persisted beyond the 24-h washout period, and like-
wise alterations in the beta receptor due to long-term
exposure may be present, either of which may predispose to
a blunted HR response. However, the results were un-
changed when adjustments were performed for long-term
beta-blocker use.
Although the Doppler indexes at supine rest indicated
the presence of abnormal LV diastolic filling, due to
technical limitations including merging of the E and A
waves, these were not measured during upright exercise.
Furthermore, tissue Doppler imaging was not performed.
Thus, the present study was unable to evaluate the contri-
bution(s) abnormal LV diastolic filling or regional systolic
function to the patients exercise intolerance. Finally, al-though all HFPEF patients had normal mitral valve mor-
phology and function at rest, it is possible that mitral
regurgitation during exercise may have contributed to the
lower peak exercise SV in this group.
By study design, participants were ambulatory outpatients
who were stable and well compensated, had no recent acute
exacerbation, and were physically able to participate in
exhaustive exercise testing. As a result, the study population
was predominantly NYHA functional class II, and not all
patients required daily diuretics. The prevalence of diuretics
(58%) was similar to that recently reported by Borlaug et al.
(58%) (35) and only slightly less (65%) than that reported in
stable HF patients undergoing exercise testing who had a
mean EF of 30% and were of similar age and NYHA
functional class (43).
Future directions. The mechanisms responsible for the
lower peak A-VO2 Diff in HFPEF patients were not
ssessed in this study; however, they may be due to impaired
eripheral vascular function (endothelial dysfunction, ab-
ormal vasodilation, reduced muscle blood flow, muscle
xygen diffusional conductance) and/or musculoskeletal
unction (skeletal muscle atrophy, reduced mitochondrial
nd capillary density) (7,10,28,44). Accordingly, future
tudies are required to determine whether interventions,
uch as regular exercise training, that improve peripheral
ascular and skeletal muscle function result in increased
xercise A-VO2 Diff and peak VO2 in HFPEF patients.
onclusions
he reduced peak VO2 in clinically stable elderly HFPEF
patients is secondary to decreased peak HR, CO, and
A-VO2 Diff. Moreover, peripheral noncardiac factors play a
rominent role in limiting exercise performance in HFPEF
atients because the change in A-VO2 Diff from rest to peak
exercise was a strong independent predictor of peak VO2.
his suggests that interventions that increase HR, skeletal
uscle perfusion, or oxygen extraction by the active muscles
ay also improve peak exercise performance in elderly
FPEF patients.
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